Danone: In context of evolving authorities’ guidance, Danone announces targeted recall of specific infant formula batches 

Rhea-AI Summary

Danone (Euronext: DANOY) announced on January 23, 2026 a targeted recall and withdrawal of a very limited number of specific infant formula batches from certain markets to comply with evolving local authorities' guidance. Danone says its routine and additional analyses confirm products remain safe and compliant with applicable safety regulations. The company invites parents and healthcare professionals to contact its careline with questions. Danone reported €27.4 billion in sales in 2024 and highlights its Renew strategy and global footprint.

Press release – Paris, January 23^rd, 2026, 6:15 PM CET

In context of evolving authorities’ guidance, Danone announces targeted recall of specific infant formula batches 

Danone never compromises on food safety. Both our routine controls and additional targeted analyses carried out in light of the current situation in the industry, confirm Danone’s products are safe and fully compliant will all applicable safety regulations.

In light of this sector situation, some local food safety authorities are evolving their guidance. In that context, as a responsible manufacturer and to comply with the latest guidance, Danone will withdraw from targeted markets a very limited number of specific batches of infant formula products.

Danone’s priority is to ensure that parents and healthcare professionals can continue to place their trust in the safety and quality of our infant formula products. 

Parents can contact Danone’s careline if they have any questions or concerns.

About Danone (www.danone.com) 

Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environment impact. Danone has defined its Renew strategy to restore growth, competitiveness, and value creation for the long-term. With over 90,000 employees, and products sold in over 120 markets, Danone generated €27.4 billion in sales in 2024. Danone’s portfolio includes leading international brands (Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, among others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Mizone, Oikos and Silk). Listed on Euronext Paris and present on the OTCQX platform via an ADR (American Depositary Receipt) program, Danone is a component stock of leading sustainability indexes including the ones managed by Moody’s and Sustainalytics, as well as MSCI ESG Indexes, FTSE4Good Index Series, Bloomberg Gender Equality Index, and Access to Nutrition Index. Danone has achieved B Corp^TM certification at global level in 2025.

o o O o o

FORWARD-LOOKING STATEMENTS

This press release contains certain forward-looking statements concerning Danone that are subject to risks and uncertainties. Generally, you can identify these forward-looking statements by forward-looking words, such as “estimate”, “expect”, “anticipate”, “project”, “plan”, “intend”, “objective”, “believe”, “forecast”, “guidance”, “foresee”, “likely”, “may”, “should”, “goal”, “target”, “might”, “will”, “could”, “predict”, “continue”, “convinced” and “confident,” the negative or plural of these words and other comparable terminology or by using future dates. Forward-looking statements in this press release include but are not limited to predictions of future activities, operations, direction, performance and results of Danone. These forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Universal Registration Document (the current version of which is available at www.danone.com).

Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell or a solicitation of an offer to buy Danone securities.

Attachment

• prdanone230126

FAQ

What did Danone (DANOY) announce on January 23, 2026 about infant formula?

Danone announced a targeted recall/withdrawal of a very limited number of specific infant formula batches from certain markets to follow evolving authorities' guidance.

Does Danone say its infant formula products are safe after the January 23, 2026 recall?

Yes; Danone states its routine controls and additional targeted analyses confirm the products are safe and compliant with applicable safety regulations.

Which markets are affected by Danone's targeted withdrawal announced January 23, 2026?

The announcement says specific batches will be withdrawn from targeted markets; it does not list which countries or markets are affected.

How can parents or healthcare professionals get more information about the Danone recall (DANOY)?

Parents and healthcare professionals are advised to contact Danone's careline for questions or concerns.

Will the January 23, 2026 recall affect Danone's 2024 sales figure of €27.4 billion?

The announcement does not quantify any expected impact on sales or financial guidance.